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Staphylococcus aureus is an important human pathogen that is also able to kill the model nematode
Caenorhabditis elegans. We constructed a 2,950-member Tn917 transposon insertion library in S. aureus strain
NCTC 8325. Twenty-one of these insertions exhibited attenuated C. elegans killing, and of these, 12 contained
insertions in different genes or chromosomal locations. Ten of these 12 insertions showed attenuated killing
phenotypes when transduced into two different S. aureus strains, and 5 of the 10 mutants correspond to genes
that have not been previously identified in signature-tagged mutagenesis studies. These latter five mutants
were tested in a murine renal abscess model, and one mutant harboring an insertion in nagD exhibited
attenuated virulence. Interestingly, Tn917 was shown to have a very strong bias for insertions near the
terminus of DNA replication.
In addition to being a common commensal bacterial species
of humans, Staphylococcus aureus is a remarkably versatile
pathogen, capable of causing a broad range of human disease
(44). The diverse range of S. aureus disease has been attributed
to its ability to produce an array of virulence factors, the
expression of which is tightly regulated by global regulatory
systems in response to cell density, energy availability, oxygen
tension, and other environmental signals (for review, see ref-
erences 8 and 32).
It has been difficult to identify S. aureus virulence factors due
to the unwieldiness of mammalian pathogenesis models. As an
alternative to traditional mammalian pathogenesis models, our
laboratory and others have utilized a strategy for studying
host-pathogen interactions, using the nematode Caenorhabditis
elegans as a simple surrogate model host (3). A variety of
human bacterial and fungal pathogens kill C. elegans, and there
is a remarkably high degree of correlation between pathogen
virulence factors required for nematode killing and virulence
in vertebrate models (39). This allows genome-wide screening
for pathogen virulence factors by a relatively high-throughput
screening procedure (15, 16, 23, 26, 29, 42, 43).
Recently, we showed that a variety of S. aureus strains effi-
ciently kill C. elegans and that S. aureus genes known to be
important in mammalian pathogenesis are also required for
nematode killing (40). As described here, we generated a
Tn917 transposon insertion library of 2,950 mutants in S. au-
reus NCTC 8325 and screened the library for attenuated killing
of C. elegans. We identified 10 genes important for virulence in
C. elegans, one of which appears to encode a previously unde-
scribed virulence factor important for pathogenicity in a mu-
rine renal abscess model.
(This work was presented in part at the 103rd General Meet-
ing of the American Society for Microbiology, Washington,
D.C., 18 to 22 May 2003.)
MATERIALS AND METHODS
Bacterial and C. elegans strains and growth conditions. Bacterial strains used
in this study are listed in Table 1. Bacterial strains and the Bristol N2 strain of C.
elegans were grown and maintained as described previously (5, 27).
Construction of an S. aureus Tn917 library. Plasmid pLTV1 (7) was electro-
porated into S. aureus strain RN4220 (38), purified (QIAprep spin mini kit;
QIAGEN), and then electroporated into S. aureus strain 8325. Strain
8325(pLTV1) was grown overnight in tryptic soy (TS) broth containing 5-g/ml
tetracycline at 30°C, 10-fold dilutions were plated on TS agar plates containing
2-g/ml erythromycin, and the plates were incubated overnight at 43°C. A total
of 2,950 colonies were picked into TS medium containing 5-g/ml erythromycin
and grown overnight at 37°C in 96-well plates. Glycerol was added (final con-
centration, 15%), and the library was stored at 80°C.
Nematode killing assay and screening protocol. S. aureus killing plates were
prepared as previously described (40). Primary screening was carried out by
transferring 20 to 30 L4-stage nematodes to each plate (27), incubating plates at
25°C, and scoring for live and dead worms after 40 h. Subsequent assays were
performed with 25 to 35 L4-stage nematodes per plate in triplicate.
Determination of Tn917 insertion site. The DNA segment adjacent to Tn917
insertion sites was determined with genomic DNA (DNeasy tissue kit; QIAGEN)
and a nested “arbitrary” PCR technique using the transposon-specific primer
Seq1 and the arbitrary primer Arb1a in the first round and the nested primers
Arb2 and Int1 in subsequent rounds (primer sequences are shown in Table 2)
(34). PCR products were purified (QIAquick PCR purification kit; QIAGEN),
sequenced with primer Int2 (Taq DyeDeoxy Terminator Cycle sequencing kit;
Applied Biosystems) in concert with an ABI 3700 PRISM automated sequencer,
and analyzed with the Vector NTI Suite 7 software package (InforMax, Inc.).
In the case of two mutants, 7G12 and 15G12, a plasmid marker rescue pro-
tocol was utilized to determine the location of the transposon insertions (7).
Briefly, Tn917 was excised from genomic DNA using EcoRI (New England
Biolabs), circularized with T4 DNA ligase (New England Biolabs), and electro-
porated into Escherichia coli DH5 (Invitrogen). Plasmid DNA was purified
from these strains, and flanking DNA was sequenced with the transposon-
specific outward-facing primers Int3 and Seq1.
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Transduction of Tn917 insertions. The general transducing phage 80 was
used as previously described (24), and transductants were confirmed by PCR
with Seq1 and a mutant-specific primer listed in Table 2.
Murine kidney abscess infections. Bacterial inocula were prepared from over-
night cultures grown at 37°C in TS medium with the appropriate antibiotic and
diluted to approximately 108 CFU/ml in TS medium. Appropriate dilutions were
prepared and plated on TS agar plates to determine the precise inoculum.
Female CD1 mice (Charles River Laboratories) were injected intraperitoneally
with 0.2 ml of the bacterial suspension, and their health was monitored daily.
Five days postchallenge, mice were sacrificed and both kidneys from each mouse
were harvested, washed in phosphate-buffered saline, weighed, and homogenized
in 2 ml of phosphate-buffered saline and colony counts were determined on TS
agar plates with appropriate antibiotics. Animal study protocols were reviewed
and approved by the Subcommittee on Animal Studies of the Massachusetts
General Hospital.
Statistical analysis. Nematode survival was calculated by the Kaplan-Meier
method, and survival differences were tested for significance by use of the log-rank
test, comparing mutant and wild-type survival curves (GraphPad Prism, version 3.0).
Differences in colonization of murine kidneys by S. aureus mutant strains and wild-
type S. aureus were tested for significance with an unpaired two-tailed t test (Graph-
Pad Prism, version 3.0). P values  0.05 were considered significant.
RESULTS
Screening a Tn917 insertion library for attenuated clones. A
2,950-member Tn917 transposon insertion library was gener-
ated by introducing the temperature-sensitive plasmid pLTV1
into S. aureus strain NCTC 8325 and selecting for erythromy-
cin-resistant clones that grew at 43°C (see Materials and Meth-
ods). The library was screened for clones that showed a de-
creased ability to kill C. elegans after 40 h in comparison to
worms feeding on wild-type S. aureus. Of 2,950 mutants
screened, 145 exhibited attenuated virulence in the primary
screen, and 21 of these, which consistently exhibited less-
pathogenic phenotypes, were selected for further analysis.
Determination of insertion site and phenotypic confirma-
tion by transduction. The insertion sites of the Tn917 trans-
posons in the 21 selected mutants were determined by an
arbitrary PCR or a plasmid marker rescue method (7, 16, 34)
TABLE 1. Strains and plasmid used in this study
Strain or plasmid Relevant genotype and/or phenotype Source or reference
Strains
S. aureus
RN4220 Restriction-deficient derivative of NCTC 8325-4 33
NCTC 8325 Wild-type strain, rsbU mutant 21; The Staphylococcal Genetic
Stock Center
Newman ATCC 25904; high level of clumping factor,
B
14; laboratory collection
ALC638 agr sarA mutant in Newman background A. L. Cheung
E. coli
OP50 Uracil auxotrophy 6; laboratory collection
DH5 Invitrogen
C. elegans
Bristol N2 Wild-type strain Caenorhabditis Genetics Center
Plasmid
pLTV1 Temperature-sensitive plasmid harboring Tn917
transposon
7
TABLE 2. Oligonucleotide primers used in this study
Primer name Primer sequence
Arbitrary PCR primers
Int1 ....................................................................................................................................CTATTCCTAAACACTTAAGAGAATTG
Int2 ....................................................................................................................................CATTGGTTTAGTGGGAATTTGTACC
Seq1...................................................................................................................................GGAGAGTATAAATTTGACTTG
Arb1a ................................................................................................................................GGCCACGCGTCGACTAGTACNNNNNNNNNNGTATA
Arb2 ..................................................................................................................................GGCCACGCGTCGACTAGTAC
Int3 ....................................................................................................................................CTCACAATAGAGAGATGTCACCGTC
Insertion-specific primers for transduction confirmation
o3H1..................................................................................................................................ATCAAGGCCGCAAGTAAATATG
o4D8..................................................................................................................................TGCCTGTTGTTTCTTATC
o5F1 ..................................................................................................................................AAATGGCTGAAACGAAGAAAGG
o6A5..................................................................................................................................GATGCTCCTGGTGATTGTTCTG
o7A2..................................................................................................................................GCATACATCATTCGTTTAG
o7G12................................................................................................................................TATCATTACCCATTACTTG
o15G12..............................................................................................................................ATTCGCATACTAAGCATTG
o25G6................................................................................................................................GTCATGCCAGAGGTTAAAG
o28G12..............................................................................................................................TTGCGCGTGATGATTATTAC
o29C3 ................................................................................................................................GTAGCCATTGCTGTAGGTATTG
o30A5................................................................................................................................TTAATTTAGAATACGGCAC
o31B11 ..............................................................................................................................GCGCCACAAATTCGTATGATTC
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as described in Materials and Methods. BLAST analysis (4)
against the S. aureus 8325 genome and the annotated S. aureus
N315 genome identified the insertion sites and associated dis-
rupted open reading frames (ORFs) in all 21 mutants (22, 25).
As shown in Table 3, eight distinct genes were directly dis-
rupted, three mutants contained insertions within 200 bp of the
5 end of three different genes, and one mutant contained a
Tn917 insertion site in intergenic sequence that was down-
stream of two convergently transcribed genes. Twelve mutants
(indicated in Table 3) with mutations corresponding to inser-
tions in 12 different genes or chromosomal locations were
chosen for further analysis. These clones resulted from Tn917
transposition and not whole plasmid integration, since all mu-
tants were tetracycline sensitive. DNA blot analysis showed
that each of these 12 mutants contained a single Tn917 inser-
tion (data not shown).
To determine whether the 12 transposon insertions chosen
for further analysis were linked to the attenuated ability to kill
C. elegans, the 12 transposon insertions were transduced into
the parent S. aureus 8325 strain by using the generalized trans-
ducing phage 80 (24). As shown in Table 3, among the 12
transduced insertions, 10 maintained their attenuation after
transduction. Figure 1 shows that these 10 mutants have sig-
nificantly decreased virulence toward C. elegans. All 10 mu-
tants grew similarly to wild-type S. aureus in TS medium, ex-
cept for mutant 30A5, which contains Tn917 inserted into the
pyrAA gene (data not shown).
Five of the 10 genes were previously identified in signature-
tagged mutagenesis (STM) screens carried out by Mei et al. (31)
(odhA and opp-2C) or Coulter et al. (11) (odhA, odhB, braB,
opp-2C, and dinG). To ensure that the attenuated phenotypes of
insertions in the five previously unidentified virulence-related
genes (citG, pyrAA, 5 yacY/tilS, 5 fbp, and nagD) (Table 3) were
not strain specific, the insertions in these five strains were trans-
duced into the S. aureus Newman strain, and the resulting trans-
ductants were tested for nematocidal activity. As shown in Fig. 2,
the transposon insertion mutations that had been verified by
transduction into 8325 also resulted in attenuated virulence com-
pared to the wild-type strain when transduced into the Newman
FIG. 1. C. elegans killing by transduced S. aureus 8325 mutants.
Shown are the fractions of nematodes killed after 39 and 43 h of
feeding on S. aureus 8325(pLTV1) and transduced isogenic Tn917
insertion mutants. Following the growth of bacteria on TS agar plates,
25 to 35 L4-stage hermaphroditic N2 worms were transferred to each
plate. Nematode death was determined after 39 and 43 h of feeding.
The data represent the mean  standard deviation (error bar) of three
sets of plates and are representative of three independent experiments.
TABLE 3. Attenuated S. aureus mutants identified by screening in C. elegans
Mutants and mutationa N315 ORFb Gene annotation Gene name/function
TCA cycle genes
3E1, 4D8, 8D9, 10B10, 22A5, 28C12,
28C11, 29E1
SA1245 odhAc,d,e 2-Oxoglutarate dehydrogenase
25G6, 29B8, 29G6 SA1244 odhBc,d,e Dihydrolipoamide succinyltransferase
7G12 SA1669 citG Fumarate hydratase, class II
Transporters
5F1 SA1239 5 braBc,d Branched chain amino acid transporter
7A2 SA1214 opp-2Cc,d,e Oligopeptide transporter membrane
permease
Nucleic acid metabolism/DNA replication
30A5 SA1045 pyrAAe Carbamoyl-phosphate synthase small chain
(pyrimidine/arginine synthesis)
3H1 SA1288 dinGc,d,e DNA helicase
28G12 SA0467 5 yacA/tilS Lysidine biosynthesis (isoleucine tRNA
synthesis)
Miscellaneous
29C3 SA2304 5 fbp Fructose-bisphosphatase
6A5 SA0790 nagD Conserved hypothetical protein
Mutants with no virulence-related phenotype
after transduction
15G12 SA1241 Similar to nitrogen oxide reductase
31B11 3 SA1239 3 braB Downstream of braB and SA1238
a Insertional mutants in boldface were transduced into 8325, and their C. elegans-killing phenotypes were confirmed.
b ORF numbers from the S. aureus N315 genome sequencing project (25).
c Previously identified in the STM screen of Mei et al. (31).
d Previously identified in the STM screen of Coulter et al. (11).
e Upregulated by agr by transcriptional profiling (13).
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strain. Transduction of insertions that did not affect virulence,
such as 15G12 (Fig. 2), did not reduce the virulence of the New-
man strain, demonstrating that transduction of Tn917 itself does
not affect C. elegans killing (not shown).
Distribution of insertion sites. Multiple mutants were recov-
ered from the screen with Tn917 insertions in the odhAB
operon (Table 3). These mutants resulted from independent
insertion events, since each insertion occurred at a different
nucleotide position (data not shown). To investigate the nature
of this apparent hot spot for transposition, the distribution of
insertion sites within the S. aureus genome was examined. As
shown in Fig. 3, there appears to be a strong bias for transpo-
sition within the region of the chromosome that lies in close
proximity to the chromosome terminus, which was estimated to
lie between 1.38 and 1.41 Mb in S. aureus strain N315 by
GC-skew analysis (25). Similar results with Tn917 were ob-
tained in our laboratory during mutagenesis of Enterococcus
faecalis strain OG1RF (17).
Examination of previously uncharacterized mutants in vivo.
The five selected insertion mutants (transduced into the Newman
strain) with mutations not previously shown to correspond to
genes relevant for mammalian pathogenesis were tested in a
modified murine renal abscess model (2). Mice were inoculated
intraperitoneally with 0.2 ml of S. aureus culture, and after a 5-day
incubation period, the kidneys were harvested and the bacterial
loads were determined. As shown in Fig. 4, inoculation of 1	 108
CFU of the wild-type Newman strain intraperitoneally resulted in
an average of 5.5 	 103 CFU/kidney at day 5. Of the mutants
tested, strain 6A5 (corresponding to an insertion in nagD) was
significantly attenuated in this model (P  0.05).
DISCUSSION
Genome-wide approaches for studying S. aureus pathogen-
esis have recently involved the use of in vivo expression tech-
nology, which uses a promoter trap library to identify genes
that are selectively transcriptionally active within the host (30),
and signature tagged mutagenesis (STM), which compares the
in vivo survival of a series of “tagged” mutants (19). Lowe et al.
used in vivo expression technology to identify 45 S. aureus
genes induced in a renal abscess model, including 6 previously
identified virulence genes (28).
Two STM experiments have been carried out with S. aureus.
Mei et al. screened a tagged library in a murine bacteremia
model and identified 50 mutants harboring insertions in mainly
biosynthetic loci (31). Coulter et al. used three different mu-
rine infection models (cutaneous abscess, bacteremia, and
wound infection) to identify 237 genes important for in vivo
FIG. 2. Survival of C. elegans on S. aureus Newman mutants. Shown
is the survival of nematodes fed S. aureus Newman (wild type, closed
squares; n 
 77) and transduced isogenic mutants 6A5 (nagD, open
diamonds; n 
 79), 7G12 (citG, open squares; n 
 80), 15G12
(SA1241, 	; n 
 79), 28G12 (5 yacA, open circles; n 
 76), 29C3 (5
fbp, open triangles; n
 71), and 30A5 (pyrAA, open inverted triangles;
n 
 76). Survival was plotted by the Kaplan-Meier method. Pairwise
comparisons (log-rank test) by strain were as follows: Newman versus
6A5, P  0.0001; Newman versus 7G12, P  0.0001; Newman versus
15G12, P not significant; Newman versus 28G12, P  0.0001; Newman
versus 29C3, P  0.0001; and Newman versus 30A5, P  0.0001.
FIG. 3. Distribution of Tn917 insertion sites within the S. aureus
genome. Shown is a schematic representation of the Tn917 insertion
sites of those mutants with reduced virulence in the C. elegans infection
model along a linearized S. aureus chromosome. Lines indicate nucle-
otide insertion sites. An enlarged depiction of the terminus region,
containing a majority of the Tn917 insertion sites, is shown above the
chromosome.
FIG. 4. Select S. aureus Newman mutants tested in a murine renal
abscess model. Groups of five CD1 mice were inoculated intraperito-
neally with the following strains: Newman (wild type; 9.8 	 107 CFU),
ALC638 (agr sarA; 1.4	 108 CFU), 6A5 (nagD; 1.4	 108 CFU), 7G12
(citG; 6.6 	 107 CFU), 28G12 (5 yacA; 5.0 	 107 CFU), 29C3 (5 fbp;
6.0 	 107 CFU), 30A5 (pyrAA; 1.4 	 108 CFU), and 15G12 (ORF
SA1241, negative control; 1.6 	 108 CFU). Five days after inoculation,
the mice were sacrificed and the kidneys were excised, homogenized,
diluted, and plated. CFU of Newman, ALC638, and Tn917 mutants in
renal tissue were calculated and plotted after log transformation. Sta-
tistical significance was determined using a two-tailed t test; compared
to wild-type strain Newman, ALC638 and 6A5 were attenuated in
renal tissue bacterial load (P  0.05). Data are representative of two
independent experiments.
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survival, the majority of which also code for biosynthesis-re-
lated enzymes (11). Genome-wide transcriptional profiling has
also been used to identify virulence-related genes. Dunman et
al. identified the set of genes regulated by the important reg-
ulatory systems agr and sar, which included many previously
identified putative virulence factors, a range of metabolic
genes, and many hypothetical genes (13). Similarly, Saı¨d-Salim
et al. defined the regulon of the transcriptional regulator rot,
which was found to negatively regulate many secreted proteins
and to positively regulate many cell wall-associated proteins
(37).
Screening a Tn917 insertion library in a pathogenicity
model. In this study, we constructed a Tn917 transposon inser-
tion mutation library in S. aureus NCTC 8325. Screening the
library resulted in the identification of 10 unique attenuated
mutants (Table 3). Five of these genes (odhA, odhB, braB,
opp-2C, and dinG) had previously been identified in the STM
screens of Coulter et al. and Mei et al. (11, 31). Additionally,
five of these genes (odhA, odhB, opp-2C, pyrAA, and dinG)
were found to be upregulated by the agr system based on
transcriptional profiling (13). While the genes identified in our
screen are associated with metabolic functions in S. aureus, all
mutants were able to grow well in TS medium, with the excep-
tion of the pyrAA mutant. The disrupted genes can be placed
into four functional categories based on the proteins they en-
code: tricarboxylic acid (TCA) cycle components, nucleic acid
metabolism/DNA replication, transporters, and miscellaneous
proteins. The same classes of genes were identified previously
in the STM screens (11, 31).
The TCA cycle appears to play several critical roles in S.
aureus pathogenesis. The TCA cycle is critical for the switch
from exponential growth to postexponential growth and the
subsequent production of capsule (12) and secretion of extra-
cellular toxins such as -hemolysin and staphylococcal entero-
toxin C (10, 41). In addition, many TCA cycle elements are
upregulated by the agr global regulatory system (13). As in
other bacterial pathogens, nucleic acid biosynthesis is impor-
tant for survival within hosts, likely due to the poor availability
of purines and pyrimidines. The two transporters identified in
this study have been previously identified as being important
for in vivo survival in the two STM screens performed in S.
aureus (11, 31) and likely reflect the importance of amino acid
and peptide uptake in the setting of infection.
Importantly, 5 out of the 10 genes (odhA, odhB, braB, opp-
2C, and dinG) identified in our in vivo screen in C. elegans were
shown previously to have reduced virulence in murine infec-
tion models (11, 31). We employed a murine kidney abscess
model to investigate the role in mammalian virulence of the
remaining five mutants that had not previously been charac-
terized in a murine infection model. Of these, the nagD mutant
was attenuated at the P 
 0.03 level. The role of nagD
(SA0790) in S. aureus virulence is not clear. It shares a high
degree of homology with B. subtilis yutF (50% identity, 68%
similarity) and E. coli nagD (31% identity, 50% similarity). In
E. coli, Peri et al. and Plumbridge independently cloned a locus
involved in N-acetylglucosamine catabolism, termed nag (35,
36). However, nagD, the 3-most member of the nagBACD
operon, is not required for N-acetylglucosamine catabolism
nor does it appear to contribute to the regulation of the operon
(35, 36). In S. aureus and B. subtilis, the N-acetylglucosamine
catabolism operon consists of nagAB only and the B. subtilis
nagD homologue yutF is in a distinct three-gene operon of
unknown function (yutDEF).
Although four of the five mutants that we tested were not
attenuated in the kidney abscess model, this does not exclude
the possibility that they may be attenuated in other animal
models. For example, of the 237 mutants Coulter et al. found
that were attenuated in at least one infection model, only 10%
of the recovered mutants were attenuated in all three models
(11). Similarly, inactivation of the aconitase gene does not
affect mouse mortality when S. aureus is inoculated intraperi-
toneally but does cause attenuation in a subcutaneous infec-
tion model (41).
Recently it was shown that S. aureus strain 8325, in which we
constructed the Tn917 library, harbors an 11-bp deletion of the
rsbU gene that decreases expression of the alternate sigma
factor B, which affects the expression of a variety of virulence-
related genes (18). Indeed reconstruction of rsbU results in
diminished agr expression and diminished expression of the
secreted proteins SspA and Hla but increased nematocidal
activity (20, 40). Therefore, to ensure that any transposon
insertions showing attenuated C. elegans killing were not spe-
cific to the 8325 background, we confirmed the phenotype of
selected mutants in the S. aureus Newman strain.
If the Tn917 insertion sites in our library were distributed
randomly, then our library of 2,950 mutants would represent
1.5 times the coverage of the nonessential regions of the
genome. However, as shown in Fig. 3, Tn917 appears to have
a strong insertion bias near the terminus of the S. aureus
chromosome. Assuming that the distribution of Tn917 inser-
tions as a whole is similar to that found among attenuated
mutants, we estimate that we have screened less than one-third
of the nonessential genes in S. aureus. Future screens may
benefit from the development of an alternative gram-positive
transposon system, such as a mariner-based system, which has
been shown to insert at random in a variety of organisms (1, 9).
In summary, we have shown that C. elegans can be used
relatively efficiently to identify S. aureus virulence factors. Six
out of 10 genes identified in C. elegans are relevant for mam-
malian pathogenesis, including the nagD gene, which was not
previously known to encode a virulence factor. Future screens
in C. elegans using a fully saturated mutant library would likely
identify additional genes involved in mammalian pathogenesis.
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ADDENDUM IN PROOF
A recent publication (T. Bae, A. K. Banger, A. Wallace, E.
M. Glass, F. Aslund, O. Schneewind, and D. M. Missiakas,
Proc. Natl. Acad. Sci. USA 101:12312–12317, 2004) describes
the construction of an ordered library of Staphylococcus aureus
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insertion mutants by using a mariner-based transposon and the
results of a screen for decreased virulence in the Caenorhab-
ditis elegans system.
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